Lumen HomepageTechnologyPipelinePress
Company Oveview
Management Team
Scientific Advisory Board

Simon Stertzer, MD.
Dr. Stertzer received his MD from the NYU School of Medicine and interned in surgery at the University of California Hospitals, San Francisco. He served as Assistant Resident in Medicine at NYU and later as Chief Medical Resident at NYU Division of Bellevue Hospital. He had a fellowship at NYU Hospital in Cardiovascular Disease.

His numerous academic and hospital appointments include Attending Cardiologist at NYU School of Medicine 1965-1983, Chief of the Hemodynamics Laboratory at Lenox Hill Hospital New York from 1971-1983, and Director of Medical Research, San Francisco Heart Institute, Seton Medical Center, Daly City, CA, 1983-1992. He is currently the Director of Experimental Angioplasty, Clinical Professor of Medicine and Associate Director of International Medical Services at Stanford University School of Medicine.

Dr. Stertzer pioneered the subspecialty of Interventional Cardiology and was the first to perform a coronary angioplasty in the United States. He has written, lectured and taught extensively about such new technologies as: 1. Treatment of acute heart attacks with angioplasty, 2. High speed Rotational Atherectomy, 3. Stent treatment of Coronary Disease, 4.Pacemaker Therapy, and 5. Drug eluting devices for coronary restenosis.

He and his staff are currently working on other leading edge technologies in genomics and coronary intervention.

© 2005-2010 Lumen Therapeutics   |   All rights reserved.   |